Central nervous and metabolic effects of intranasally applied leptin

Endocrinology

Volumn 145, Issue 6, 2004, Pages 2696-2701

  Schulz, Carla ^a,b   Paulus, Kerstin ^a   Lehnert, Hendrik ^a  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; LEPTIN; NEUROPEPTIDE Y;

AFFECT; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARCUATE NUCLEUS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CIRCULATION; CENTRAL NERVOUS SYSTEM FUNCTION; CONTROLLED STUDY; DRUG PENETRATION; EMOTION; FLUID INTAKE; FOOD INTAKE; MALE; METABOLIC REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THALAMUS MIDLINE NUCLEUS; UPREGULATION; WEIGHT GAIN;

ADMINISTRATION, INTRANASAL; AMYGDALA; ANIMALS; CENTRAL NERVOUS SYSTEM; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; HORMONES; HYPOTHALAMUS; LEPTIN; MALE; NEUROPEPTIDE Y; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 2542433123     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-1431     Document Type: Article

References (37)

1. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM 1996 Leptin enters the brain by a saturable system independent of insulin. Peptides 17:305-311
2. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman JM 1997 Physiological response to long-term peripheral and central leprin infusion in lean and obese mice. Proc Natl Acad Sci USA 94:8878-8883
3. Levin N, Nelson C, Gurney A, Vandlen R, De Sauvage F 1996 Decreased food intake does not completely account for adiposity reduction after ob protein infusion. Proc Natl Acad Sci USA 93:1726-1730
4. Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PL, Sinha MK, Considine RV 1996 Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348:159-161
5. Banks WA, Clever CM, Farrell CL 2000 Partial saturation and regional variation in the blood-to-brain transport of leptin in normal weight mice. Am J Physiol Endocrinol Metab 278:E1158-E1165
6. Gizurarson S 1990 Animal models for intranasal drug delivery studies. A review article. Acta Pharm Nord 2:105-122
7. Kern W, Born J, Schreiber H, Fehm HL 1999 Central nervous system effects of intranasally administered insulin during euglycemia in men. Diabetes 48:557-563
8. Erdtmann-Vourliotis M, Mayer P, Riechert U, Handel M, Kriebitzsch J, Hollt V 1999 Rational design of oligonucleotide probes to avoid optimization steps in in situ hybridization. Brain Res Brain Res Protoc 4:82-91
9. Sakane T, Akizuki M, Taki Y, Yamashita S, Sezaki H, Nadai T 1995 Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the molecular weight of drugs. J Pharm Pharmacol 47:379-381
10. Deurloo MJ, Hermens WA, Romeyn SG, Verhoef JC, Merkus FW 1989 Absorption enhancement of intranasally administered insulin by sodium taurodihydrofusidate (STDHF) in rabbits and rats. Pharm Res 6:853-856
11. Grill HJ, Schwartz MW, Kaplan JM, Foxhall JS, Breininger J, Baskin DG 2002 Evidence that the caudal brainstem is a target for the inhibitory effect of leptin on food intake. Endocrinology 143:239-246
12. Nowak KW, Pierzchala-Koziec K, Tortorella C, Nussdorfer GG, Malendowicz LK 2002 Effects of prolonged leptin infusion on rat pituitary-adrenocortical function. Int J Mol Med 9:61-64
13. Ahima RS, Kelly J, Elmquist JK, Flier JS 1999 Distinct physiologic and neuronal responses to decreased leptin and mild hyperleptinemia. Endocrinology 140:4923-4931
14. Chen Y, Heiman ML 2000 Chronic leptin administration promotes lipid utilization until fat mass is greatly reduced and preserves lean mass of normal female rats. Regul Pept 92:113-119
15. El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, Flier JS 2000 Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 105:1827-1832
16. Scarpace PJ, Matheny M, Zhang Y, Shek EW, Prima V, Zolotukhin S, Tumer N 2002 Leptin-induced leptin resistance reveals separate roles for the anorexic and thermogenic responses in weight maintenance. Endocrinology 143:3026-3035
17. Bagnasco M, Dube MG, Kalra PS, Kalra SP 2002 Evidence for the existence of distinct central appetite, energy expenditure, and ghrelin stimulation pathways as revealed by hypothalamic site-specific leptin gene therapy. Endocrinology 143:4409-4421
18. Rozhavskaya-Arena M, Lee DW, Leinung MC, Grasso P 2000 Design of a synthetic leptin agonist: effects on energy balance, glucose homeostasis, and thermoregulation. Endocrinology 141:2501-2507
19. Cullen MJ, Ling N, Foster AC, Pelleymounter MA 2001 Urocortin, corticotropin releasing factor-2 receptors and energy balance. Endocrinology 142:992-999
20. Heinrichs SC, Li DL, Iyengar S 2001 Corticotropin-releasing factor (CRF) or CRF binding-protein ligand inhibitor administration suppresses food intake in mice and elevates body temperature in rats. Brain Res 900:177-185
21. Wieczorek I, Schulz C, Jarry H, Lehnert H 2001 The effects of the selective serotonin reuptake-inhibitor fluvoxamine on body weight in Zucker rats are mediated by corticotropin-releasing hormone. Int J Obes Relat Metab Disord 25:1566-1569
22. Gardner JD, Rothwell NJ, Luheshi GN 1998 Leptin affects food intake via CRF-receptor-mediated pathways. Nat Neurosci 1:103
23. Jang M, Romsos DR 1998 Neuropeptide Y and corticotropin-releasing hormone concentrations within specific hypothalamic regions of lean but not ob/ob mice respond to food-deprivation and refeeding. J Nutr 128:2520-2525
24. Hakansson ML, Brown H, Ghilardi N, Skoda RC, Meister B 1998 Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci 18:559-572
25. Jang M, Mistry A, Swick AG, Romsos DR 2000 Leptin rapidly inhibits hypothalamic neuropeptide Y secretion and stimulates corticotropin-releasing hormone secretion in adrenalectomized mice. J Nutr 130:2813-2820
26. Costa A, Poma A, Martignoni E, Nappi G, Ur E, Grossman A 1997 Stimulation of corticotrophin-releasing hormone release by the obese (ob) gene product, leptin, from hypothalamic explants. Neuroreport 8:1131-1134
27. Uehara Y, Shimizu H, Ohtani K, Sato N, Mori M 1998 Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin. Diabetes 47:890-893
28. Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG 1996 Identification of targets of leptin action in rat hypothalamus. J Clin Invest 98:1101-1106
29. Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, Porte DJ, Woods SC, Seeley RJ, Weigle DS 1996 Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45:531-535
30. Nishiyama M, Makino S, Asaba K, Hashimoto K 1999 Leptin effects on the expression of type-2 CRH receptor mRNA in the ventromedial hypothalamus in the rat. J Neuroendocrinol 11:307-314
31. Baskin DG, Breininger JF, Schwartz MW 1999 Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes 48:828-833
32. Holland PC, Petrovich GD, Gallagher M 2002 The effects of amygdala lesions on conditioned stimulus-potentiated eating in rats. Physiol Behav 76:117-129
33. Ganaraj B, Jeganathan PS 1998 Involvement of basolateral nucleus, central nucleus of amygdala in the regulation of ingestive behaviour in rat. Indian J Med Res 108:98-103
34. Raber J, Chen S, Mucke L, Feng L 1997 Corticotropin-releasing factor and adrenocorticotrophic hormone as potential central mediators of OB effects. J Biol Chem 272:15057-15060
35. Plamondon H, Merali Z 1997 Regulation of ingestion by CRF and bombesin-like peptides: distinct meal-related peptide level changes. Am J Physiol 272:R268-R274
36. Merali Z, McIntosh J, Kent P, Michaud D, Anisman H 1998 Aversive and appetitive events evoke the release of corticotropin-releasing hormone and bombesin-like peptides at the central nucleus of the amygdala. J Neurosci 18:4758-4766
37. Lasiter PS, Glanzman DL 1985 Cortical substrates of taste aversion learning: involvement of dorsolateral amygdaloid nuclei and temporal neocortex in taste aversion learning. Behav Neurosci 99:257-276